Literature DB >> 33370324

Clustering fibromyalgia patients: A combination of psychosocial and somatic factors leads to resilient coping in a subgroup of fibromyalgia patients.

Alexandra Braun1, Dimitar Evdokimov1, Johanna Frank1, Paul Pauli2, Nurcan Üçeyler1, Claudia Sommer1.   

Abstract

BACKGROUND: Coping strategies and their efficacy vary greatly in patients suffering from fibromyalgia syndrome (FMS).
OBJECTIVE: We aimed to identify somatic and psychosocial factors that might contribute to different coping strategies and resilience levels in FMS. SUBJECTS AND METHODS: Standardized questionnaires were used to assess coping, pain, and psychological variables in a cohort of 156 FMS patients. Quantitative real-time polymerase chain reaction (qRT-PCR) determined gene expression of selected cytokines in white blood cells of 136 FMS patients and 25 healthy controls. Data of skin innervation, functional and structural sensory profiles of peripheral nociceptive nerve fibers of a previous study were included into the statistics. An exploratory factor analysis was used to define variance explaining factors, which were then included into cluster analysis.
RESULTS: 54.9% of the variance was explained by four factors which we termed (1) affective load, (2) coping, (3) pain, and (4) pro-inflammatory cytokines (p < 0.05). Considering differences in the emerged factors, coping strategies, cytokine profiles, and disability levels, 118 FMS patients could be categorized into four clusters which we named "maladaptive", "adaptive", "vulnerable", and "resilient" (p < 0.05). The adaptive cluster had low scores in disability and in all symptom categories in contrast to the vulnerable cluster, which was characterized by high scores in catastrophizing and disability (p < 0.05). The resilient vs. the maladaptive cluster was characterized by better coping and a less pro-inflammatory cytokine pattern (p < 0.05).
CONCLUSION: Our data suggest that problem- and emotion-focused coping strategies and an anti-inflammatory cytokine pattern are associated with reduced disability and might promote resilience. Additional personal factors such as low anxiety scores, ability of acceptance, and persistence further favor a resilient phenotype. Individualized therapy should take these factors into account.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33370324      PMCID: PMC7769259          DOI: 10.1371/journal.pone.0243806

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  68 in total

1.  A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment.

Authors:  Gianni Belcaro; Morio Hosoi; Luciano Pellegrini; Giovanni Appendino; Edmondo Ippolito; Andrea Ricci; Andrea Ledda; Mark Dugall; Maria Rosaria Cesarone; Claudia Maione; Giovanna Ciammaichella; Domenico Genovesi; Stefano Togni
Journal:  Phytother Res       Date:  2013-06-15       Impact factor: 5.878

2.  Conceptualizing resilience in adult mental health literature: A systematic review and narrative synthesis.

Authors:  Nadia Ayed; Sarah Toner; Stefan Priebe
Journal:  Psychol Psychother       Date:  2018-06-11       Impact factor: 3.915

3.  [Resilience as a protective personality characteristic in the elderly].

Authors:  Karena Leppert; Thomas Gunzelmann; Jörg Schumacher; Bernhard Strauss; Elmar Brähler
Journal:  Psychother Psychosom Med Psychol       Date:  2005-08

4.  Maltreatment in childhood and adolescence: results from a survey of a representative sample of the German population.

Authors:  Winfried Häuser; Gabriele Schmutzer; Elmar Brähler; Heide Glaesmer
Journal:  Dtsch Arztebl Int       Date:  2011-04-29       Impact factor: 5.594

5.  Identification and Validation of Clinically Relevant Clusters of Severe Fatigue in Rheumatoid Arthritis.

Authors:  Neil Basu; Gareth T Jones; Gary J Macfarlane; Katie L Druce
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

6.  Understanding the Association of Fatigue With Other Symptoms of Fibromyalgia: Development of a Cluster Model.

Authors:  Nada Lukkahatai; Brian Walitt; Alexandra Espina; Alves Gelio; Leorey N Saligan
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

7.  Small fibre pathology in patients with fibromyalgia syndrome.

Authors:  Nurcan Üçeyler; Daniel Zeller; Ann-Kathrin Kahn; Susanne Kewenig; Sarah Kittel-Schneider; Annina Schmid; Jordi Casanova-Molla; Karlheinz Reiners; Claudia Sommer
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501

Review 8.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

9.  Adaptation profiles comprising objective and subjective measures in fibromyalgia: the al-Ándalus project.

Authors:  Fernando Estévez-López; Víctor Segura-Jiménez; Inmaculada C Álvarez-Gallardo; Milkana Borges-Cosic; Manuel Pulido-Martos; Ana Carbonell-Baeza; Virginia A Aparicio; Rinie Geenen; Manuel Delgado-Fernández
Journal:  Rheumatology (Oxford)       Date:  2017-11-01       Impact factor: 7.580

10.  Illness duration and coping style in chronic fatigue syndrome.

Authors:  Molly M Brown; Abigail A Brown; Leonard A Jason
Journal:  Psychol Rep       Date:  2010-04
View more
  1 in total

1.  Coping and Beliefs as Predictors of Functioning and Psychological Adjustment in Fibromyalgia Subgroups.

Authors:  Laura Rubio Fidel; Azucena García-Palacios; Rocío Herrero; Guadalupe Molinari; Carlos Suso-Ribera
Journal:  Pain Res Manag       Date:  2022-04-14       Impact factor: 2.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.